Advertisement
Screener

Imunon, Inc. (IMNN) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

Imunon, Inc. Operating Cash Flow

Imunon, Inc. (IMNN) reported Operating Cash Flow of -$7.01 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-11

  • Imunon, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$3.03M.
  • Imunon, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$3.99M.
  • Imunon, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$3.66M.
  • Imunon, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$4.44M.
  • Imunon, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$13.90M.
  • Imunon, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$18.85M.
  • Imunon, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$19.02M.
  • Imunon, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$23.10M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 3 month as first filedNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 6 month as first filedNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 9 month as first filedNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 12 month as first filed
2026-06-30-$3.03M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11
-$7.01M
10-Q · filed 2026-08-11
-$10.67M
derived: sum of 3 quarters · filed 2026-08-11
-$15.11M
derived: sum of 4 quarters · filed 2026-08-11
2026-03-31-$3.99M
10-Q · filed 2026-05-12
-$7.64M
derived: sum of 2 quarters · filed 2026-05-12
-$12.08M
derived: sum of 3 quarters · filed 2026-05-12
-$15.03M
derived: sum of 4 quarters · filed 2026-08-11
2025-12-31-$3.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
-$8.10M
derived: sum of 2 quarters · filed 2026-03-31
-$11.05M
derived: sum of 3 quarters · filed 2026-08-11
-$13.90M
10-K · filed 2026-03-31
2025-09-30-$4.44M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$7.39M
derived: sum of 2 quarters · filed 2026-08-11
-$10.24M
10-Q · filed 2025-11-13
-$14.66M
derived: sum of 4 quarters · filed 2026-08-11
2025-06-30-$2.95M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11
-$5.80M
10-Q · filed 2026-08-11
-$10.22M
derived: sum of 3 quarters · filed 2026-08-11
-$14.27M
derived: sum of 4 quarters · filed 2026-08-11
2025-03-31-$2.85M
10-Q · filed 2026-05-12
-$7.27M
derived: sum of 2 quarters · filed 2026-05-12
-$11.32M
derived: sum of 3 quarters · filed 2026-05-12
-$15.83M
derived: sum of 4 quarters · filed 2026-05-12
2024-12-31-$4.42M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
-$8.48M
derived: sum of 2 quarters · filed 2026-03-31
-$12.98M
derived: sum of 3 quarters · filed 2026-03-31
-$18.85M
10-K · filed 2026-03-31
2024-09-30-$4.06M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$8.56M
derived: sum of 2 quarters · filed 2025-11-13
-$14.43M
10-Q · filed 2025-11-13
-$18.21M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30-$4.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05
-$10.38M
10-Q · filed 2025-08-05
-$14.15M
derived: sum of 3 quarters · filed 2025-08-05
-$18.62M
derived: sum of 4 quarters · filed 2025-08-05
2024-03-31-$5.87M
10-Q · filed 2025-05-12
-$9.65M
derived: sum of 2 quarters · filed 2025-05-12
-$14.12M
derived: sum of 3 quarters · filed 2025-05-12
-$20.91M
derived: sum of 4 quarters · filed 2025-05-12
2023-12-31-$3.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
-$8.25M
derived: sum of 2 quarters · filed 2025-02-27
-$15.04M
derived: sum of 3 quarters · filed 2025-02-27
-$19.02M
10-K · filed 2025-02-27
2023-09-30-$4.47M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
-$11.27M
derived: sum of 2 quarters · filed 2024-11-07
-$15.25M
10-Q · filed 2024-11-07
-$20.26M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30-$6.79M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
-$10.78M
10-Q · filed 2024-08-14
-$10.78M
10-Q · filed 2023-08-10
-$15.78M
derived: sum of 3 quarters · filed 2024-08-14
-$20.42M
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31-$3.98M
10-Q · filed 2024-05-13
-$4.09M
10-Q · filed 2023-05-11
-$8.99M
derived: sum of 2 quarters · filed 2024-05-13
-$13.63M
derived: sum of 3 quarters · filed 2024-05-13
-$19.10M
derived: sum of 4 quarters · filed 2024-05-13
2022-12-31-$5.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
-$9.65M
derived: sum of 2 quarters · filed 2024-03-28
-$15.12M
derived: sum of 3 quarters · filed 2024-03-28
-$23.10M
10-K · filed 2024-03-28
-$23.13M
10-K · filed 2023-03-30
2022-09-30-$4.64M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
-$10.11M
derived: sum of 2 quarters · filed 2023-11-14
-$18.09M
10-Q · filed 2023-11-14
-$18.07M
10-Q · filed 2022-11-14
-$23.18M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30-$5.47M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
-$13.45M
10-Q · filed 2023-08-10
-$13.39M
10-Q · filed 2022-08-15
-$18.54M
derived: sum of 3 quarters · filed 2023-08-10
-$22.32M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31-$7.98M
10-Q · filed 2023-05-11
-$13.06M
derived: sum of 2 quarters · filed 2023-05-11
-$16.85M
derived: sum of 3 quarters · filed 2023-05-11
-$19.46M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31-$5.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30
-$8.87M
derived: sum of 2 quarters · filed 2023-03-30
-$11.49M
derived: sum of 3 quarters · filed 2023-03-30
-$16.22M
10-K · filed 2023-03-30
2021-09-30-$3.79M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
-$6.40M
derived: sum of 2 quarters · filed 2022-11-14
-$11.14M
10-Q · filed 2022-11-14
-$14.87M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30-$2.61M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
-$7.35M
10-Q · filed 2022-08-15
-$11.08M
derived: sum of 3 quarters · filed 2022-08-15
-$15.04M
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31-$4.74M
10-Q · filed 2022-05-16
-$8.47M
derived: sum of 2 quarters · filed 2022-05-16
-$12.43M
derived: sum of 3 quarters · filed 2022-05-16
-$15.38M
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31-$3.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
-$7.70M
derived: sum of 2 quarters · filed 2022-03-31
-$10.64M
derived: sum of 3 quarters · filed 2022-03-31
-$15.62M
10-K · filed 2022-03-31
2020-09-30-$3.96M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
-$6.91M
derived: sum of 2 quarters · filed 2021-11-15
-$11.89M
10-Q · filed 2021-11-15
-$17.50M
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30-$2.95M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
-$7.92M
10-Q · filed 2021-08-12
-$13.54M
derived: sum of 3 quarters · filed 2021-08-12
-$18.02M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31-$4.98M
10-Q · filed 2021-05-14
-$10.59M
derived: sum of 2 quarters · filed 2021-05-14
-$15.07M
derived: sum of 3 quarters · filed 2021-05-14
-$19.70M
derived: sum of 4 quarters · filed 2021-05-14
2019-12-31-$5.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19
-$10.10M
derived: sum of 2 quarters · filed 2021-03-19
-$14.72M
derived: sum of 3 quarters · filed 2021-03-19
-$20.26M
10-K · filed 2021-03-19
2019-09-30-$4.48M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16
-$9.11M
derived: sum of 2 quarters · filed 2020-11-16
-$14.64M
10-Q · filed 2020-11-16
-$8.56M
derived: sum of 4 quarters · filed 2020-11-16
2019-06-30-$4.63M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14
-$10.16M
10-Q · filed 2020-08-14
-$4.08M
derived: sum of 3 quarters · filed 2020-08-14
-$8.34M
derived: sum of 4 quarters · filed 2020-08-14
2019-03-31-$5.54M
10-Q · filed 2020-05-15
$550.43K
derived: sum of 2 quarters · filed 2020-05-15
-$3.72M
derived: sum of 3 quarters · filed 2020-05-15
-$7.92M
derived: sum of 4 quarters · filed 2020-05-15
2018-12-31$6.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25
$1.82M
derived: sum of 2 quarters · filed 2020-03-25
-$2.39M
derived: sum of 3 quarters · filed 2020-03-25
-$7.04M
10-K · filed 2020-03-25
2018-09-30-$4.27M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14
-$8.47M
derived: sum of 2 quarters · filed 2019-11-14
-$13.13M
10-Q · filed 2019-11-14
-$13.08M
10-Q · filed 2018-11-14
-$17.34M
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30-$4.21M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
-$8.86M
10-Q · filed 2019-08-14
-$8.81M
10-Q · filed 2018-08-14
-$13.07M
derived: sum of 3 quarters · filed 2019-08-14
-$18.18M
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31-$4.66M
10-Q · filed 2019-05-15
-$8.86M
derived: sum of 2 quarters · filed 2019-05-15
-$13.97M
derived: sum of 3 quarters · filed 2019-05-15
-$18.17M
derived: sum of 4 quarters · filed 2019-05-15
2017-12-31-$4.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29
-$9.32M
derived: sum of 2 quarters · filed 2019-03-29
-$13.51M
derived: sum of 3 quarters · filed 2019-03-29
-$16.64M
10-K · filed 2019-03-29
2017-09-30-$5.11M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14
-$9.30M
derived: sum of 2 quarters · filed 2018-11-14
-$12.43M
10-Q · filed 2018-11-14
-$17.10M
derived: sum of 4 quarters · filed 2018-11-14
2017-06-30-$4.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14
-$7.33M
10-Q · filed 2018-08-14
-$11.99M
derived: sum of 3 quarters · filed 2018-08-14
-$16.71M
derived: sum of 4 quarters · filed 2018-08-14
2017-03-31-$3.13M
10-Q · filed 2018-05-11
-$7.79M
derived: sum of 2 quarters · filed 2018-05-11
-$12.52M
derived: sum of 3 quarters · filed 2018-05-11
-$16.77M
derived: sum of 4 quarters · filed 2018-05-11
2016-12-31-$4.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-27
-$9.39M
derived: sum of 2 quarters · filed 2018-03-27
-$13.64M
derived: sum of 3 quarters · filed 2018-03-27
-$18.38M
10-K · filed 2018-03-27
2016-09-30-$4.72M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
-$8.97M
derived: sum of 2 quarters · filed 2017-11-14
-$13.72M
10-Q · filed 2017-11-14
-$17.62M
derived: sum of 4 quarters · filed 2017-11-14
2016-06-30-$4.25M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15
-$8.99M
10-Q · filed 2016-08-15
-$12.89M
derived: sum of 3 quarters · filed 2017-03-24
-$18.21M
derived: sum of 4 quarters · filed 2017-03-24
2016-03-31-$4.74M
10-Q · filed 2016-05-16
-$8.64M
derived: sum of 2 quarters · filed 2017-03-24
-$13.96M
derived: sum of 3 quarters · filed 2017-03-24
-$19.64M
derived: sum of 4 quarters · filed 2017-03-24
2015-12-31-$3.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24
-$9.22M
derived: sum of 2 quarters · filed 2017-03-24
-$14.89M
derived: sum of 3 quarters · filed 2017-03-24
-$20.83M
10-K · filed 2017-03-24
2015-09-30-$5.32M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10
-$11.00M
derived: sum of 2 quarters · filed 2016-11-10
-$16.93M
10-Q · filed 2016-11-10
-$23.44M
derived: sum of 4 quarters · filed 2016-11-10
2015-06-30-$5.67M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15
-$11.61M
10-Q · filed 2016-08-15
-$18.12M
derived: sum of 3 quarters · filed 2016-08-15
-$23.96M
derived: sum of 4 quarters · filed 2016-08-15
2015-03-31-$5.94M
10-Q · filed 2016-05-16
-$12.45M
derived: sum of 2 quarters · filed 2016-05-16
-$18.28M
derived: sum of 3 quarters · filed 2016-05-16
-$22.47M
derived: sum of 4 quarters · filed 2016-05-16
2014-12-31-$6.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
-$12.35M
derived: sum of 2 quarters · filed 2016-03-30
-$16.53M
derived: sum of 3 quarters · filed 2016-03-30
-$21.35M
10-K · filed 2016-03-30
2014-09-30-$5.84M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
-$10.02M
derived: sum of 2 quarters · filed 2015-11-05
-$14.84M
10-Q · filed 2015-11-05
-$18.31M
derived: sum of 4 quarters · filed 2016-03-30
2014-06-30-$4.18M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10
-$9.01M
10-Q · filed 2015-08-10
-$12.47M
derived: sum of 3 quarters · filed 2016-03-30
-$15.13M
derived: sum of 4 quarters · filed 2016-03-30
2014-03-31-$4.82M
10-Q · filed 2015-05-11
-$4.84M
10-Q · filed 2014-05-08
-$8.29M
derived: sum of 2 quarters · filed 2016-03-30
-$10.95M
derived: sum of 3 quarters · filed 2016-03-30
-$16.14M
derived: sum of 4 quarters · filed 2016-03-30
2013-12-31-$3.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
-$6.13M
derived: sum of 2 quarters · filed 2016-03-30
-$11.32M
derived: sum of 3 quarters · filed 2016-03-30
-$9.53M
10-K · filed 2016-03-30
-$9.47M
10-K · filed 2014-03-13
2013-09-30-$2.66M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
-$7.85M
derived: sum of 2 quarters · filed 2014-11-10
-$6.06M
10-Q · filed 2014-11-10
-$6.36M
10-Q · filed 2013-11-12
-$12.04M
derived: sum of 4 quarters · filed 2015-03-12
2013-06-30-$5.19M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07
-$3.40M
10-Q · filed 2014-08-07
-$3.59M
10-Q · filed 2013-08-08
-$9.38M
derived: sum of 3 quarters · filed 2015-03-12
-$14.63M
derived: sum of 4 quarters · filed 2015-03-12
2013-03-31$1.79M
10-Q · filed 2014-05-08
-$4.19M
derived: sum of 2 quarters · filed 2015-03-12
-$9.44M
derived: sum of 3 quarters · filed 2015-03-12
-$14.63M
derived: sum of 4 quarters · filed 2015-03-12
2012-12-31-$5.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12
-$11.23M
derived: sum of 2 quarters · filed 2015-03-12
-$16.42M
derived: sum of 3 quarters · filed 2015-03-12
-$22.14M
10-K · filed 2015-03-12
-$22.33M
10-K · filed 2013-03-18
2012-09-30-$5.25M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
-$10.44M
derived: sum of 2 quarters · filed 2013-11-12
-$16.17M
10-Q · filed 2013-11-12
-$20.61M
derived: sum of 4 quarters · filed 2014-03-13
2012-06-30-$5.18M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08
-$10.91M
10-Q · filed 2013-08-08
-$15.35M
derived: sum of 3 quarters · filed 2014-03-13
-$22.26M
derived: sum of 4 quarters · filed 2014-03-13
2012-03-31-$5.73M
10-Q · filed 2013-05-09
-$10.17M
derived: sum of 2 quarters · filed 2014-03-13
-$17.07M
derived: sum of 3 quarters · filed 2014-03-13
-$24.10M
derived: sum of 4 quarters · filed 2014-03-13
2011-12-31-$4.44M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13
-$11.34M
derived: sum of 2 quarters · filed 2014-03-13
-$18.37M
derived: sum of 3 quarters · filed 2014-03-13
-$22.74M
10-K · filed 2014-03-13
2011-09-30-$6.91M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09
-$13.93M
derived: sum of 2 quarters · filed 2012-11-09
-$18.30M
10-Q · filed 2012-11-09
-$21.07M
derived: sum of 4 quarters · filed 2013-03-18
2011-06-30-$7.03M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14
-$11.40M
10-Q · filed 2012-08-14
-$14.17M
derived: sum of 3 quarters · filed 2013-03-18
-$17.95M
derived: sum of 4 quarters · filed 2013-03-18
2011-03-31-$4.37M
10-Q · filed 2012-05-15
-$7.14M
derived: sum of 2 quarters · filed 2013-03-18
-$10.93M
derived: sum of 3 quarters · filed 2013-03-18
2010-12-31-$2.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
-$6.56M
derived: sum of 2 quarters · filed 2013-03-18
-$13.37M
10-K · filed 2013-03-18
2010-09-30-$3.78M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10
-$10.60M
10-Q · filed 2011-11-10
2010-06-30-$6.81M
10-Q · filed 2011-08-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
SOLIGENIX, INC. (SNGX)United States$0.008B
EXICURE, INC. (XCUR)United States$0.008B-1.54
Traws Pharma, Inc. (TRAW)United States$0.009B-0.58
Alzamend Neuro, Inc. (ALZN)United States$0.009B
Ensysce Biosciences, Inc. (ENSC)United States$0.008B-0.37
InMed Pharmaceuticals Inc. (INM)$0.008B-0.65
Apimeds Pharmaceuticals US, Inc. (APUS)United States$0.008B
FibroBiologics, Inc. (FBLG)United States$0.009B-0.27
CNS Pharmaceuticals, Inc. (CNSP)United States$0.007B
Acurx Pharmaceuticals, Inc. (ACXP)United States$0.007B-0.97